» Articles » PMID: 31507162

Mass Spectrometry Imaging of N-Glycans from Formalin-Fixed Paraffin-Embedded Tissue Sections Using a Novel Subatmospheric Pressure Ionization Source

Overview
Journal Anal Chem
Specialty Chemistry
Date 2019 Sep 12
PMID 31507162
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

N-linked glycosylation, featuring various glycoforms, is one of the most common and complex protein post-translational modifications (PTMs) controlling protein structures and biological functions. It has been revealed that abnormal changes of protein N-glycosylation patterns are associated with many diseases. Hence, unraveling the disease-related alteration of glycosylation, especially the glycoforms, is crucial and beneficial to improving our understanding about the pathogenic mechanisms of various diseases. In past decades, given the capability of in situ mapping of biomolecules and their region-specific localizations, matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) has been widely applied to the discovery of potential biomarkers for many diseases. In this study, we coupled a novel subatmospheric pressure (SubAP)/MALDI source with a Q Exactive HF hybrid quadrupole-orbitrap mass spectrometer for in situ imaging of N-linked glycans from formalin-fixed paraffin-embedded (FFPE) tissue sections. The utility of this new platform for N-glycan imaging analysis was demonstrated with a variety of FFPE tissue sections. A total of 55 N-glycans were successfully characterized and visualized from a FFPE mouse brain section. Furthermore, 29 N-glycans with different spatial distribution patterns could be identified from a FFPE mouse ovarian cancer tissue section. High-mannose N-glycans exhibited elevated expression levels in the tumor region, indicating the potential association of this type of N-glycans with tumor progression.

Citing Articles

Seeing is Believing: Developing Multimodal Metabolic Insights at the Molecular Level.

Chadha R, Guerrero J, Wei L, Sanchez L ACS Cent Sci. 2024; 10(4):758-774.

PMID: 38680555 PMC: 11046475. DOI: 10.1021/acscentsci.3c01438.


Mass spectrometry imaging methods for visualizing tumor heterogeneity.

Duncan K, Petrosova H, Lum J, Goodlett D Curr Opin Biotechnol. 2024; 86:103068.

PMID: 38310648 PMC: 11520788. DOI: 10.1016/j.copbio.2024.103068.


Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction.

Liu S, Tu C, Zhang H, Huang H, Liu Y, Wang Y J Ovarian Res. 2024; 17(1):26.

PMID: 38281033 PMC: 10821556. DOI: 10.1186/s13048-024-01350-2.


Enhanced Detection of Charged -Glycans in the Brain by Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometric Imaging.

Samal J, Palomino T, Chen J, Muddiman D, Segura T Anal Chem. 2023; 95(29):10913-10920.

PMID: 37427925 PMC: 10640919. DOI: 10.1021/acs.analchem.3c00494.


MS-based glycomics: An analytical tool to assess nervous system diseases.

Peng W, Kobeissy F, Mondello S, Barsa C, Mechref Y Front Neurosci. 2022; 16:1000179.

PMID: 36408389 PMC: 9671362. DOI: 10.3389/fnins.2022.1000179.


References
1.
Chen H, Deng Z, Huang C, Wu H, Zhao X, Li Y . Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Tumour Biol. 2017; 39(7):1010428317716249. DOI: 10.1177/1010428317716249. View

2.
Lukowski J, Weaver E, Hummon A . Analyzing Liposomal Drug Delivery Systems in Three-Dimensional Cell Culture Models Using MALDI Imaging Mass Spectrometry. Anal Chem. 2017; 89(16):8453-8458. PMC: 5567673. DOI: 10.1021/acs.analchem.7b02006. View

3.
Anugraham M, Jacob F, Nixdorf S, Everest-Dass A, Heinzelmann-Schwarz V, Packer N . Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status. Mol Cell Proteomics. 2014; 13(9):2213-32. PMC: 4159645. DOI: 10.1074/mcp.M113.037085. View

4.
Wong N, Easton R, Panico M, Sutton-Smith M, Morrison J, Lattanzio F . Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J Biol Chem. 2003; 278(31):28619-34. DOI: 10.1074/jbc.M302741200. View

5.
Roby K, TAYLOR C, Sweetwood J, Cheng Y, Pace J, Tawfik O . Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis. 2000; 21(4):585-91. DOI: 10.1093/carcin/21.4.585. View